Search results for "Complement"

showing 10 items of 2113 documents

Current neuroscientific research database findings of brain activity changes after hypnosis.

2021

Using multi-modal brain imaging techniques we found pronounced changes in neuronal activity after hypnotic trance induction whereby state changes seem to occur synchronously with the specific induction instructions. In clinical patients, hypnosis proved to be a powerful method in inhibiting the reaction of the fear circuitry structures. The aim of the present paper is to critically discuss the limitations of the current neuroscientific research database in the light of a debate in defining relevant hypnotic constructs and to suggest ideas for future research projects. We discuss the role of hypnotic suggestibility (HS), the impact of hypnotic inductions and the importance of the depth of hy…

HypnosisBrain activity and meditation05 social sciencesTranceSuggestibilityBrain050109 social psychologyCognitionGeneral Medicine03 medical and health sciences0302 clinical medicineComplementary and alternative medicineNeuroimagingHumans0501 psychology and cognitive sciencesDatabase researchPsychologySuggestion030217 neurology & neurosurgeryHypnosisCognitive psychologyThe American journal of clinical hypnosis
researchProduct

Analgesic hypnotic treatment in a post-stroke patient

2021

In recent years, hypnotic suggestions have been used in several clinical conditions. This treatment is often used for anxiety treatment, somatization, and post-traumatic stress disorder. Hypnotic analgesia is one of the most clinically useful phenomena of hypnosis. The article describes the case of a patient who underwent hypnotic treatments for hypersensitivity and chronic pain. Results showed an improvement of pain control and a decrease of pain hypersensibility. In addition, during rehabilitative treatments, the patient reported a high level of compliance with the multidisciplinary team. These findings suggest that hypnosis could be a useful treatment for post-stroke pain management.

Hypnosismedicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentAnalgesic050109 social psychologyHypnotic03 medical and health sciences0302 clinical medicinemedicineHumansHypnotics and Sedatives0501 psychology and cognitive sciencesPain MeasurementAnalgesicsRehabilitationbusiness.industry05 social sciencesChronic painGeneral Medicinemedicine.diseaseComplementary and alternative medicinePost strokePhysical therapyAnxietyAnalgesiamedicine.symptombusinessSomatizationHypnosis030217 neurology & neurosurgeryAmerican Journal of Clinical Hypnosis
researchProduct

Medicinal Plants in the Treatment of Depression. II: Evidence from Clinical Trials

2021

AbstractDepression is a syndrome characterized by deep sadness and the inhibition of psychic functions, sometimes accompanied by neurovegetative disorders, with symptoms of anxiety almost always present. The disease produces alterations in a variety of neural networks and neurotransmission systems, along with a dysfunction of the hypothalamic-pituitary-adrenal axis, which leads to concomitant alterations in the immunological response. Generally, there is a parallel increase in proinflammatory mediators as well as oxidative and nitrosative damage caused by a reduction of antioxidant defenses. In a previous review, we compiled and examined studies of medicinal plants that had been evaluated i…

Hypothalamo-Hypophyseal SystemPituitary-Adrenal SystemPharmaceutical ScienceDiseaseBioinformaticsAntioxidantsAnalytical Chemistry03 medical and health sciences0302 clinical medicineDrug DiscoveryHumansMedicineMedicinal plantsDepression (differential diagnoses)PharmacologyPlants MedicinalKavaDepressionbusiness.industryOrganic ChemistryAntidepressive Agents030227 psychiatryClinical trialSystematic reviewComplementary and alternative medicineMolecular MedicineAntidepressantAnxietymedicine.symptombusinessHypericum030217 neurology & neurosurgeryPhytotherapySystematic Reviews as TopicPlanta Medica
researchProduct

Post-translational modifications in the survival motor neuron protein

2004

Spinal muscular atrophy (SMA) is an autosomal recessive disease characterized by a progressive loss of the spinal motoneurons. The SMA-determining gene has been termed survival motor neuron (SMN) and is deleted or mutated in over 98% of patients. The encoded gene product is a protein expressed as different isoforms. In particular, we showed that the rat SMN cDNA produces two isoforms with Mr of 32 and 35 kDa, both localized in nuclear coiled bodies, but the 32 kDa form is also cytoplasmic, whereas the 35 kDa form is also microsomal. To determine the molecular relationship between these two isoforms and potential post-translational modifications, we performed transfection experiments with a …

INVOLVEMENTFORMSPRODUCTBiochemistryMiceChlorocebus aethiopsProtein IsoformsPhosphorylationCyclic AMP Response Element-Binding ProteinSMN PROTEINCells CulturedMotor NeuronsSPINAL MUSCULAR-ATROPHYRNA-Binding ProteinsSMN Complex Proteins3T3 CellsTransfectionmedicine.anatomical_structureSpinal CordCOS CellsSUBCELLULAR-LOCALIZATIONEXPRESSIONGene isoformRecombinant Fusion ProteinsBiophysicsNerve Tissue ProteinsBiologyMuscular Atrophy SpinalGene productSMN Complex ProteinsComplementary DNAmedicineAnimalsHumansMolecular BiologyCell BiologySpinal muscular atrophyMotor neuronmedicine.diseaseSurvival of Motor Neuron 1 ProteinMolecular biologyRatsnervous system diseasesMolecular WeightSEVERITYnervous systemBODIESProtein Processing Post-TranslationalDETERMINING GENEImmunostainingBiochemical and Biophysical Research Communications
researchProduct

Opsonizing activities of IgG, IgM antibodies and the C3b inactivator-cleaved third component of complement in macrophage phagocytosis

1976

Phagocytosis of SRBC by guinea-pig peritoneal macrophages is enhanced by opsonizing IgG antibody alone. IgM antibody requires the presence of bound C3. Treatment of C3b coated SRBC with purified C3b inactivator (yielding EAIgM C1423d) does not reduce attachment to, and phagocytosis by, peritoneal macrophages. This finding suggests the existence of a C3d receptor on peritoneal macrophages. EC43b intermediates which have been produced by removing IgM antibody by mercaptoethanol treatment and by subsequent removal of C1 and C2, are phagocytosed despite the absence of IgM antibody. Furthermore, treatment of EC43b with C3b inactivator does not change phagocytosis. Thus, IgM antibody does not app…

Igm antibodyReceptors DrugPhagocytosisGuinea PigsImmunologychemical and pharmacologic phenomenaStimulationToxicologyMicrobiologyMacrophage phagocytosisPhagocytosisOpsonin ProteinsC3b inactivatorAnimalsPharmacology (medical)ReceptorPharmacologybiologyChemistryMacrophagesCell MembraneComplement C3Complement System ProteinsOpsonin ProteinsImmunoglobulin MImmunoglobulin GImmunologybiology.proteinAntibodyAgents and Actions
researchProduct

Complement genetics: biological implications of polymorphisms and deficiencies

1999

Abstract Complement (C) proteins form a highly complex and important humoral host immune defence system. A recent meeting**The VII Complement Genetics Workshop and Conference was held at Mainz, Germany, on 21–23 May 1998. addressed the role of genetic studies of C components and its regulators with respect to evolution, function and human disease.

Immune defenceGeneticsHuman diseaseImmunologyBiologyFunction (biology)Complement (complexity)Immunology Today
researchProduct

Immunohistological differential diagnosis of inflammatory colonic diseases.

1984

Immunohistological investigations were carried out on human colonic tissue from, I healthy mucosa, 2 slightly inflamed mucosa, 3 mucosa with ulcerative colitis, 4 mucosa with Crohn's colitis, using antibodies against immunoglobulins and complement components. All our antibodies, including F(ab')2 fragments, demonstrated a progressive increase of labelled cells from healthy mucosa through slightly inflamed mucosa to mucosa with ulcerative colitis, in contrast to a complete absence of labelled cells in cases of Crohn's disease. The results are discussed with regard to their pathogenesis and their clinical significance for the differentiation of ulcerative colitis and Crohn's colitis.

Immunoglobulin Amedicine.medical_specialtyPathologyHistologyComplement Activating EnzymesGastroenterologyPathology and Forensic MedicinePathogenesisDiagnosis DifferentialCrohn DiseaseInternal medicinemedicineHumansColitisCrohn's diseasebiologybusiness.industryHistocytochemistryComplement C1qImmunochemistryComplement C4General MedicineComplement C3medicine.diseaseColitisUlcerative colitisdigestive system diseasesImmunoglobulin AImmunoglobulin MImmunoglobulin Mbiology.proteinImmunohistochemistryColitis UlcerativeAntibodybusinessGranulocytesHistopathology
researchProduct

Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications.

2012

We performed an immunogenetic analysis of 345 IGHV-IGHD-IGHJ rearrangements from 337 cases with primary splenic small B-cell lymphomas of marginal-zone origin. Three immunoglobulin (IG) heavy variable (IGHV) genes accounted for 45.8% of the cases (IGHV1-2, 24.9%; IGHV4-34, 12.8%; IGHV3-23, 8.1%). Particularly for the IGHV1-2 gene, strong biases were evident regarding utilization of different alleles, with 79/86 rearrangements (92%) using allele *04. Among cases more stringently classified as splenic marginal-zone lymphoma (SMZL) thanks to the availability of splenic histopathological specimens, the frequency of IGHV1-2*04 peaked at 31%. The IGHV1-2*04 rearrangements carried significantly lo…

Immunoglobulin geneModels MolecularCancer ResearchGenes Immunoglobulin Heavy ChainGene Rearrangement B-Lymphocyte Heavy ChainImmunoglobulin Variable RegionSomatic hypermutationSplenic NeoplasmBiologyCohort StudiesantigenmedicineHumansSplenic marginal zone lymphomaAlleleGeneticsSplenic Neoplasmssplenic marginal-zone lymphomaHematologyGene rearrangementLymphoma B-Cell Marginal Zonemedicine.diseasePrognosisComplementarity Determining Regionssomatic hypermutationimmunoglobulin geneOncologyMutationIGHDsplenic marginal-zone lymphoma; immunoglobulin gene; somatic hypermutation; CDR3; antigenCDR3IGHV@Leukemia
researchProduct

C4 DNA RFLP reference typing report.

1990

One hundred and three individual DNA samples (including 23 families) were studied at the gene level during the reference typing of the fourth component of human complement at the VIth Complement Genetics Workshop in Mainz (1989). All samples were analyzed with the restriction enzyme Taq I and with two DNA probes recognizing the 5' ends of both C4 genes and the two adjacent 21-hydroxylase genes. This RFLP is informative for the number of C4 genes as well as for their respective gene size. We found a high degree of variation regarding the number of C4 genes, i.e. haplotypes with 1-3 structural C4 genes of 16 or 22 kb size. By correlating these haplotypes to the complotypes obtained by protein…

ImmunologyBiologyMajor Histocompatibility Complexchemistry.chemical_compoundHumansTypingDeoxyribonucleases Type II Site-SpecificGeneAllelesGeneticsModels GeneticHybridization probeHaplotypeGenetic VariationComplement C4HematologyDNARestriction enzymeBlotting SouthernchemistryHaplotypesMultilocus sequence typingSteroid 21-HydroxylaseRestriction fragment length polymorphismDNAPolymorphism Restriction Fragment LengthComplement and inflammation
researchProduct

Binding to complement factors and activation of the alternative pathway by Acanthamoeba.

2010

Acanthamoeba can cause severe ocular and cerebral diseases in healthy and immunocompromised individuals, respectively. Activation of complement appears to play an important role in host defence against infection. The exact mechanism, however, is still unclear. The aim of the present study was to investigate the effect of normal human serum (NHS) and normal mouse serum (NMS) on Acanthamoeba trophozoites, the binding of different complement factors to Acanthamoeba and the activation of the complement system. Moreover, we aimed to work out any possible differences between different strains of Acanthamoeba. A virulent T4 strain, a non-virulent T4 strain and a virulent T6 strain were included in…

ImmunologyComplement Pathway AlternativeVirulenceAcanthamoebaComplement factor IAntigen-Antibody ComplexImmunofluorescenceMannose-Binding LectinBacterial AdhesionMicrobiologyMiceSpecies Specificityparasitic diseasesmedicineImmunology and AllergyAnimalsHumansTrophozoitesIncubationEdetic AcidMice Knockoutmedicine.diagnostic_testbiologyVirulenceComplement C1qHematologyAmebiasisComplement C3biology.organism_classificationComplement C9Complement systemAcanthamoebaMice Inbred C57BLAlternative complement pathwayIntracellularImmunobiology
researchProduct